Viaderma Revenue vs. Working Capital
| VDRM Stock | USD 0.01 0.00 0.00% |
For Viaderma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Viaderma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Viaderma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Viaderma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Viaderma over time as well as its relative position and ranking within its peers.
Viaderma |
Viaderma Working Capital vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Viaderma's current stock value. Our valuation model uses many indicators to compare Viaderma value to that of its competitors to determine the firm's financial worth. Viaderma is rated fifth in revenue category among its peers. It is rated first in working capital category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Viaderma's earnings, one of the primary drivers of an investment's value.Viaderma Revenue vs. Competition
Viaderma is rated fifth in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 142.63 Million. Viaderma adds roughly 44,691 in revenue claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Viaderma Working Capital vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Viaderma |
| = | 44.69 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Viaderma |
| = | (445 K) |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Viaderma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Viaderma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Viaderma will eventually generate negative long term returns. The profitability progress is the general direction of Viaderma's change in net profit over the period of time. It can combine multiple indicators of Viaderma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Viaderma Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Viaderma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Viaderma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Viaderma's important profitability drivers and their relationship over time.
Use Viaderma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Viaderma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viaderma will appreciate offsetting losses from the drop in the long position's value.Viaderma Pair Trading
Viaderma Pair Trading Analysis
The ability to find closely correlated positions to Viaderma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Viaderma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Viaderma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Viaderma to buy it.
The correlation of Viaderma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viaderma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viaderma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Viaderma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Viaderma position
In addition to having Viaderma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Exotic Funds Thematic Idea Now
Exotic Funds
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Viaderma Pink Sheet
To fully project Viaderma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Viaderma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Viaderma's income statement, its balance sheet, and the statement of cash flows.